Back to Cetera Investment Advisers Cetera Investment Advisers

TMDX

22 quarters

Position history for Cetera Investment AdvisersCetera Investment Advisers's holdings in TransMedics Group, Inc.

Yes. Cetera Investment Advisers holds 10,542 shares of TMDX (TransMedics Group), worth $700,200, as of its Q2 2026 13F filing. It reduced the position by 6,531 shares (-38.3%) from Q1 2026. Cetera Investment Advisers has held TMDX since Q1 2021, across 22 quarterly 13F filings.

Current Value

$700,200

Current Shares

10,542

Total Value Change

+$455,200

Total Shares Change

+4,635

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
10,542
-38.3%
$700,2000.0%$66.42
0
2026-Q1
Increased
17,073
+58.5%
$1.7M0.0%$99.41
37
2025-Q4
Increased
10,771
+26.3%
$1.3M0.0%$121.65
31
2025-Q3
Increased
8,531
+34.9%
$957,1780.0%$112.20
32
2025-Q2
Increased
6,325
+56.8%
$847,6130.0%$134.01
35
2025-Q1
Decreased
4,033
-51.2%
$271,3400.0%$67.28
0
2024-Q4
Increased
8,260
+8.3%
$515,0110.0%$62.35
26
2024-Q3
Decreased
7,626
-12.4%
$1.2M0.0%$157.00
0
2024-Q2
Decreased
8,705
-21.6%
$1.3M0.0%$150.62
0
2024-Q1
Increased
11,106
+30.6%
$821,1780.0%$73.94
31
2023-Q4
Increased
8,503
+12.1%
$671,1420.0%$78.93
27
2023-Q3
Increased
7,585
+3.2%
$415,2790.0%$54.75
25
2023-Q2
Increased
7,350
+2.7%
$617,2530.0%$83.98
25
2023-Q1
Decreased
7,154
-20.9%
$541,7720.0%$75.73
0
2022-Q4
Increased
9,049
+22.4%
$558,5040.0%$61.72
29
2022-Q3
Decreased
7,391
-27.1%
$309,0000.0%$41.74
0
2022-Q2
Increased
10,134
+0.3%
$319,0000.0%$31.45
23
2022-Q1
Decreased
10,108
-11.3%
$272,0000.0%$26.94
0
2021-Q4
Increased
11,400
+6.8%
$218,0000.0%$19.16
25
2021-Q3
Increased
10,676
+2.8%
$353,0000.0%$33.09
24
2021-Q2
Increased
10,389
+75.9%
$345,0000.0%$33.18
36
2021-Q1
New
5,907
-
$245,0000.0%$41.49
32

Other major holders of TMDX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used